AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox


Praxis Precision Medicines, Inc.'s (PRAX) stock price increased as the company announced the pricing of its $150 million public offering at $35.50 per share. Additionally, positive preliminary results were reported from PRAX-628 study in treating epilepsy patients, with full results expected in Q1 2024.


Knowing stock market today at a glance
Daily stocks & crypto headlines, free to your inbox
Comments

No comments yet